- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)
Total 13 results
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer | Solid Tumors | Programmed Cell Death-1 (PD1, PD-1) | Programmed Cell Death 1 Ligand 1(PDL1, PD-L1) | Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)Japan
-
Sanjay Gandhi Postgraduate Institute of Medical...RecruitingBreast Cancer | Tumor Infiltrating Lymphocytes | Programmed Cell Death Ligand 1India
-
Nantes University HospitalUnknownBullous Pemphigoid | Immunotherapy | Programmed Cell Death Ligand 1France
-
Assiut UniversityUnknownProgrammed Cell Death 1Egypt
-
Second Affiliated Hospital, School of Medicine,...Zhejiang Cancer Hospital; Sun Yat-sen University; Ningbo Medical Center Lihuili... and other collaboratorsRecruitingPlaque, Atherosclerotic | Programmed Cell Death Protein 1 InhibitorChina
-
Tongji HospitalRecruitingHepatocellular Carcinoma | Effects of Immunotherapy | Programmed Cell Death 1China
-
Sun Yat-sen UniversityNot yet recruitingCervical Cancer | Chemotherapy Effect | Neoadjuvant Therapy | Programmed Cell Death 1 Receptor / Antagonists & Inhibitors
-
Shanghai Jiao Tong University School of MedicineCompletedOral Cancer | Induction Chemotherapy | Programmed Cell Death 1 Inhibitor | Inductive TherapyChina
-
Shanghai Jiao Tong University School of MedicineCompletedOral Cancer | VEGFR2 Inhibitor | Programmed Cell Death 1 Inhibitor | Inductive TherapyChina
-
Lei LiRecruitingRecurrent Cervical Carcinoma | Radiotherapy | Immunotherapy | Survival Outcomes | Immune Checkpoint Inhibitors | Objective Response Rate | Metastatic Cervical Carcinoma | Tislelizumab | Persistent Cervical Carcinoma | Anti-programmed Cell Death Receptor 1China
-
Second Affiliated Hospital, School of Medicine,...RecruitingCarotid Artery Plaque | Plaque, Atherosclerotic | Immune Checkpoint Inhibitors | Programmed Cell Death Protein 1 Inhibitor | Intimal Medial Thickness of Internal Carotid ArteryChina
-
Sun Yat-sen UniversityRecruitingMuscle-Invasive Bladder Carcinoma | Radiotherapy | Programmed Cell Death Protein 1 InhibitorChina
-
Lei LiRecruitingCervical Carcinoma | Immunotherapy | Survival Outcomes | Adverse Events | Locally Advanced Cervical Cancer | Chemoradiotherapy | Immune Checkpoint Inhibitor | Anti-programmed Cell Death Receptor 1 | Early Stage Cervical CancerChina